Has Peter Blessey, MD received payments from drug or device companies?

Yes. Drug and device makers reported $3,158 in general payments to Peter Blessey, MD across 41 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Peter Blessey, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Peter Blessey, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Peter Blessey, MD

Sports Medicine · Slidell, LANPI 1467488163

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (42.1%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by ALON Medical Technology at 43.0% of the total. That places this record below the midpoint for sports medicine clinicians in LA, where the typical reported total is $3,045.

$3,158in general payments, 2019–2025

Across 41 payments — averaging $77.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

ALON Medical Technology$1K
Zimmer Biomet$824
Stryker$226
Pacira Therapeutics, Inc.$158
Vericel Corporation$119
Orthalign Inc$79
plus $394 from 11 others

What the payments were for

Travel & lodging$62620%
Food & beverage$1,20138%
Education$1,33142%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
ALON Medical Technology	2	$1,358
Zimmer Biomet	8	$824
Stryker	6	$226
Pacira Therapeutics, Inc.	5	$158
Vericel Corporation	2	$119
Orthalign Inc	1	$79
Siemens Medical Solutions USA, Inc.	1	$66
Pacira Pharmaceuticals Incorporated	3	$58
Omnilife Science, Inc	1	$46
Innovation Technologies Inc	1	$37
Smith+Nephew	2	$34
Bioventus LLC	1	$32
Microport Orthopedics Inc	3	$27
Sanofi-aventis U.S. LLC	2	$25
Vertex	1	$23
Heron Therapeutics, Inc.	1	$23
Sanara Medtech Inc.	1	$21

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Oxford$541
Zilretta$115
MACI$100

How this compares

$3,158 in reported general payments places this provider in the 50th percentile of 82 sports medicine providers in Louisiana.

See all sports medicine providers in Louisiana →

Medicare billing

Part B allowed, 2024

$74,356

Medicare patients

340

Services billed

789

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	98	$607
Warfarin Sodium	49	$207
Cephalexin	48	$207
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	18	$98
Meloxicam	31	$71

Paid to pharmacies, not to this prescriber.